XML 66 R45.htm IDEA: XBRL DOCUMENT v3.23.1

Quarterly Financial Information (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2022

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information

Impairment of Long-Lived Assets

In August 2022, the Company revised its financial outlook, which the Company identified as an indicator of impairment for the Company’s Aarki asset group. In the third quarter of 2022, the Company recorded an impairment loss of $47.6 million on intangible assets related to the Aarki acquisition.

The Company subsequently noted additional indicators of impairment during the fourth quarter of 2022, most notably sharp declines in the Company’s stock price and market capitalization near the end of 2022. During the assessment performed as of December 31, 2022, it was determined that there was an error in the Company’s identification of the Aarki asset group in the impairment analysis performed as of August 31, 2022. As a result, the impairment loss in the third quarter of 2022 was understated by $3.6 million in the consolidated statements of operations and comprehensive loss, and the related intangible assets as of September 30, 2022 were overstated in the consolidated balance sheets.

This error is incremental to the errors discussed in Note 3 for the understatement of end-user liability, reserve for indirect tax liabilities, and other adjustments which also had impacts to the previously issued 2022, 2021 and 2020 quarterly consolidated financial statements. In connection therewith, the Company has made adjustments to its previously issued 2022, 2021 and 2020 quarterly financial information to correct these errors and other immaterial misstatements for such periods. The following tables for each of the quarters in the years ended December 31, 2022, 2021 and 2020 reflect the quarterly information as filed in the Company’s Quarterly Report on Form 10-Q for the periods ended September 30, 2022, 2021 and 2020, June 30, 2022, 2021 and 2020, and March 31, 2022, 2021 and 2020, as restated for these errors.

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss, Fiscal Year 2022

The following unaudited condensed consolidated statements of operations and comprehensive loss tables present the impacts of the restatement adjustments for the periods ended September 30, 2022, 2021 and 2020, June 30, 2022, 2021 and 2020, and March 31, 2022, 2021 and 2020 (in thousands, except for per share amounts). For the impacts of the restatement adjustments for the statements of operations and comprehensive loss for the year ended December 31, 2021 and 2020, refer to Note 3 - Restatement of Previously Issued Consolidated Financial Statements. The year ended December 31, 2022 was not subject to restatement and is presented in Part 1 of Item 8. Financial Statements.

			Three Months Ended September 30, 2022
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Revenue			$	60,255					$	(71)					$	(856)					$	—					$	(112)					$	59,216
Costs and expenses:
Cost of revenue			7,555						—						—						(245)						289						7,599
Research and development			8,354						—						—						—						(417)						7,937
Sales and marketing			51,773						(84)						—						(2)						(207)						51,480
General and administrative			20,280						—						152						(21)						525						20,936
Impairment of goodwill and long-lived assets			47,581						—						—						3,649						—						51,230
Total costs and expenses			135,543						(84)						152						3,381						190						139,182
Loss from operations			(75,288)						13						(1,008)						(3,381)						(302)						(79,966)
Interest expense, net			(3,807)						—						—						—						—						(3,807)
Change in fair value of common stock warrant liabilities			(80)						—						—						—						—						(80)
Other income, net			508						—						—						—						—						508
Loss before income taxes			(78,667)						13						(1,008)						(3,381)						(302)						(83,345)
Benefit for income taxes			(120)						—						—						—						—						(120)
Net loss			$	(78,547)					$	13					$	(1,008)					$	(3,381)					$	(302)					$	(83,225)
Net loss per share attributable to common stockholders:
Basic			$	(0.19)					$	—					$	—					$	(0.01)					$	—					$	(0.20)
Diluted			$	(0.19)					$	—					$	—					$	(0.01)					$	—					$	(0.20)
Other comprehensive loss:
Change in unrealized loss on available-for-sale investments, net of tax			139						—						—						—						—						139
Total other comprehensive loss			$	139					$	—					$	—					$	—					$	—					$	139
Total comprehensive loss			$	(78,408)					$	13					$	(1,008)					$	(3,381)					$	(302)					$	(83,086)

			Three Months Ended June 30, 2022
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Revenue			$	73,335					$	(83)					$	(1,470)					$	—					$	(25)					$	71,757
Costs and expenses:
Cost of revenue			9,020						—						—						—						(17)						9,003
Research and development			18,529						—						—						—						(276)						18,253
Sales and marketing			73,185						1,053						—						—						(507)						73,731
General and administrative			26,712						—						184						—						(15)						26,881
Impairment of goodwill and long-lived assets			—						—						—						—						—						—
Total costs and expenses			127,446						1,053						184						—						(815)						127,868
Loss from operations			(54,111)						(1,136)						(1,654)						—						790						(56,111)
Interest expense, net			(7,596)						—						—						—						—						(7,596)
Change in fair value of common stock warrant liabilities			1,023						—						—						—						—						1,023
Other expense, net			(82)						—						—						—						—						(82)
Loss before income taxes			(60,766)						(1,136)						(1,654)						—						790						(62,766)
Benefit for income taxes			(155)						—						—						—						—						(155)
Net loss			$	(60,611)					$	(1,136)					$	(1,654)					$	—					$	790					$	(62,611)
Net loss per share attributable to common stockholders: (1)
Basic			$	(0.15)					$	—					$	—					$	—					$	—					$	(0.16)
Diluted			$	(0.15)					$	—					$	—					$	—					$	—					$	(0.16)
Other comprehensive loss:
Change in unrealized loss on available-for-sale investments, net of tax			(577)						—						—						—						—						(577)
Total other comprehensive loss			$	(577)					$	—					$	—					$	—					$	—					$	(577)
Total comprehensive loss			$	(61,188)					$	(1,136)					$	(1,654)					$	—					$	790					$	(63,188)

(1) Due to differences in rounding to the nearest cent per basic or diluted share, totals may not equal the sum of the line items.

			Three Months Ended March 31, 2022
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Revenue			$	93,438					$	(52)					$	(1,435)					$	—					$	(87)					$	91,864
Costs and expenses:
Cost of revenue			9,265						—						—						—						(65)						9,200
Research and development			18,653						—						—						—						(3)						18,650
Sales and marketing			117,332						630						—						—						(617)						117,345
General and administrative			92,792						—						(76)						—						7						92,723
Impairment of goodwill and long-lived assets			—						—						—						—						—						—
Total costs and expenses			238,042						630						(76)						—						(678)						237,918
Loss from operations			(144,604)						(682)						(1,359)						—						591						(146,054)
Interest expense, net			(8,157)						—						—						—						—						(8,157)
Change in fair value of common stock warrant liabilities			4,462						—						—						—						—						4,462
Other expense, net			(27)						—						—						—						(1)						(28)
Loss before income taxes			(148,326)						(682)						(1,359)						—						590						(149,777)
Benefit for income taxes			(213)						—						—						—						—						(213)
Net loss			$	(148,113)					$	(682)					$	(1,359)					$	—					$	590					$	(149,564)
Net loss per share attributable to common stockholders:
Basic			$	(0.37)					$	—					$	—					$	—					$	—					$	(0.37)
Diluted			$	(0.37)					$	—					$	—					$	—					$	—					$	(0.37)
Other comprehensive loss:
Change in unrealized loss on available-for-sale investments, net of tax			(2,046)						—						—						—						—						(2,046)
Total other comprehensive loss			$	(2,046)					$	—					$	—					$	—					$	—					$	(2,046)
Total comprehensive loss			$	(150,159)					$	(682)					$	(1,359)					$	—					$	590					$	(151,610)

Condensed Consolidated Statements of Operations and Comprehensive Loss, Fiscal Year 2021

			Three Months Ended December 31, 2021
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Revenue			$	108,849					$	(41)					$	(1,114)					$	—					$	506					$	108,200
Costs and expenses:
Cost of revenue			8,422						—						—						—						—						8,422
Research and development			15,433						—						—						—						311						15,744
Sales and marketing			155,080						531						—						—						(207)						155,404
General and administrative			33,934						—						192						—						122						34,248
Impairment of goodwill and long-lived assets			—						—						—						—						—						—
Total costs and expenses			212,869						531						192						—						226						213,818
Loss from operations			(104,020)						(572)						(1,306)						—						280						(105,618)
Interest expense, net			(1,086)						—						—						—						—						(1,086)
Change in fair value of common stock warrant liabilities			6,024						—						—						—						—						6,024
Other expense, net			(59)						—						—						—						—						(59)
Loss before income taxes			(99,141)						(572)						(1,306)						—						280						(100,739)
Benefit for income taxes			(170)						—						—						—						(144)						(314)
Net loss			$	(98,971)					$	(572)					$	(1,306)					$	—					$	424					$	(100,425)
Net loss per share attributable to common stockholders:
Basic			$	(0.25)					$	—					$	—					$	—					$	—					$	(0.25)
Diluted			$	(0.25)					$	—					$	—					$	—					$	—					$	(0.25)
Other comprehensive loss:
Change in unrealized loss on available-for-sale investments, net of tax			(248)						—						—						—						—						(248)
Total other comprehensive loss			$	(248)					$	—					$	—					$	—					$	—					$	(248)
Total comprehensive loss			$	(99,219)					$	(572)					$	(1,306)					$	—					$	424					$	(100,673)

			Three Months Ended September 30, 2021
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Revenue			$	102,072					$	(34)					$	(1,008)					$	—					$	(506)					$	100,524
Costs and expenses:
Cost of revenue			7,647						—						—						—						532						8,179
Research and development			13,162						—						—						—						(96)						13,066
Sales and marketing			114,531						636						—						—						(339)						114,828
General and administrative			48,376						—						176						—						(38)						48,514
Impairment of goodwill and long-lived assets			—						—						—						—						—						—
Total costs and expenses			183,716						636						176						—						59						184,587
Loss from operations			(81,644)						(670)						(1,184)						—						(565)						(84,063)
Interest expense, net			(87)						—						—						—						—						(87)
Change in fair value of common stock warrant liabilities			113,601						—						—						—						—						113,601
Other expense, net			(22)						—						—						—						—						(22)
Income before income taxes			31,848						(670)						(1,184)						—						(565)						29,429
Benefit for income taxes			(18,933)						—						—						—						—						(18,933)
Net income			$	50,781					$	(670)					$	(1,184)					$	—					$	(565)					$	48,362
Net income (loss) loss per share attributable to common stockholders:
Basic			$	0.13					$	—					$	(0.01)					$	—					$	—					$	0.12
Diluted			$	(0.16)					$	—					$	—					$	—					$	—					$	(0.16)
Other comprehensive loss:
Change in unrealized loss on available-for-sale investments, net of tax			—						—						—						—						—						—
Total other comprehensive loss			$	—					$	—					$	—					$	—					$	—					$	—
Total comprehensive loss			$	50,781					$	(670)					$	(1,184)					$	—					$	(565)					$	48,362

			Three Months Ended June 30, 2021
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Revenue			$	89,491					$	(38)					$	(891)					$	—					$	—					$	88,562
Costs and expenses:
Cost of revenue			4,386						—						—						—						—						4,386
Research and development			10,140						—						—						—						—						10,140
Sales and marketing			99,523						475						—						—						—						99,998
General and administrative			25,432						—						169						—						—						25,601
Impairment of goodwill and long-lived assets			—						—						—						—						—						—
Total costs and expenses			139,481						475						169						—						—						140,125
Loss from operations			(49,990)						(513)						(1,060)						—						—						(51,563)
Interest expense, net			(25)						—						—						—						—						(25)
Change in fair value of common stock warrant liabilities			(29,595)						—						—						—						—						(29,595)
Other income, net			80						—						—						—						—						80
Loss before income taxes			(79,530)						(513)						(1,060)						—						—						(81,103)
Provision for income taxes			65						—						—						—						—						65
Net loss			$	(79,595)					$	(513)					$	(1,060)					$	—					$	—					$	(81,168)
Net loss per share attributable to common stockholders:
Basic			$	(0.21)					$	—					$	—					$	—					$	—					$	(0.21)
Diluted			$	(0.21)					$	—					$	—					$	—					$	—					$	(0.21)
Other comprehensive loss:
Change in unrealized loss on available-for-sale investments, net of tax			—						—						—						—						—						—
Total other comprehensive loss			$	—					$	—					$	—					$	—					$	—					$	—
Total comprehensive loss			$	(79,595)					$	(513)					$	(1,060)					$	—					$	—					$	(81,168)

			Three Months Ended March 31, 2021
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Revenue			$	83,677					$	(25)					$	(784)					$	—					$	—					$	82,868
Costs and expenses:
Cost of revenue			4,256						—						—						—						—						4,256
Research and development			7,282						—						—						—						—						7,282
Sales and marketing			96,323						138						—						—						—						96,461
General and administrative			27,284						—						155						—						—						27,439
Impairment of goodwill and long-lived assets			—						—						—						—						—						—
Total costs and expenses			135,145						138						155						—						—						135,438
Loss from operations			(51,468)						(163)						(939)						—						—						(52,570)
Interest expense, net			(24)						—						—						—						—						(24)
Change in fair value of common stock warrant liabilities			(2,108)						—						—						—						—						(2,108)
Other income, net			50						—						—						—						—						50
Loss before income taxes			(53,550)						(163)						(939)						—						—						(54,652)
Provision for income taxes			42						—						—						—						—						42
Net loss			$	(53,592)					$	(163)					$	(939)					$	—					$	—					$	(54,694)
Net loss per share attributable to common stockholders:
Basic			$	(0.15)					$	—					$	—					$	—					$	—					$	(0.15)
Diluted			$	(0.16)					$	—					$	—					$	—					$	—					$	(0.16)
Other comprehensive loss:
Change in unrealized loss on available-for-sale investments, net of tax			—						—						—						—						—						—
Total other comprehensive loss			$	—					$	—					$	—					$	—					$	—					$	—
Total comprehensive loss			$	(53,592)					$	(163)					$	(939)					$	—					$	—					$	(54,694)

			Three Months Ended December 31, 2020
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Revenue			$	67,723					$	(25)					$	(321)					$	—					$	—					$	67,377
Costs and expenses:
Cost of revenue			3,475						—						—						—						—						3,475
Research and development			9,972						—						—						—						—						9,972
Sales and marketing			79,560						1,179						—						—						—						80,739
General and administrative			17,953						—						53						—						—						18,006
Impairment of goodwill and long-lived assets			—						—						—						—						—						—
Total costs and expenses			110,960						1,179						53						—						—						112,192
Loss from operations			(43,237)						(1,204)						(374)						—						—						(44,815)
Interest expense, net			(28)						—						—						—						—						(28)
Change in fair value of common stock warrant liabilities			(23,049)						—						—						—						—						(23,049)
Other expense, net			(651)						—						—						—						—						(651)
Loss before income taxes			(66,965)						(1,204)						(374)						—						—						(68,543)
Provision for income taxes			15						—						—						—						—						15
Net loss			$	(66,980)					$	(1,204)					$	(374)					$	—					$	—					$	(68,558)
Net loss per share attributable to common stockholders:(1)
Basic			$	(0.22)					$	—					$	—					$	—					$	—					$	(0.23)
Diluted			$	(0.22)					$	—					$	—					$	—					$	—					$	(0.23)
Other comprehensive loss:
Change in unrealized loss on available-for-sale investments, net of tax			—						—						—						—						—						—
Total other comprehensive loss			$	—					$	—					$	—					$	—					$	—					$	—
Total comprehensive loss			$	(66,980)					$	(1,204)					$	(374)					$	—					$	—					$	(68,558)

(1) Due to differences in rounding to the nearest cent per basic or diluted share, totals may not equal the sum of the line items.

			Three Months Ended September 30, 2020
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Revenue			$	59,955					$	(19)					$	(252)					$	—					$	—					$	59,684
Costs and expenses:
Cost of revenue			3,102						—						—						—						—						3,102
Research and development			4,369						—						—						—						—						4,369
Sales and marketing			73,187						390						—						—						—						73,577
General and administrative			7,861						—						44						—						—						7,905
Impairment of goodwill and long-lived assets			—						—						—						—						—						—
Total costs and expenses			88,519						390						44						—						—						88,953
Loss from operations			(28,564)						(409)						(296)						—						—						(29,269)
Interest expense, net			(24)						—						—						—						—						(24)
Change in fair value of common stock warrant liabilities			—						—						—						—						—						—
Other expense, net			(14,216)						—						—						—						—						(14,216)
Loss before income taxes			(42,804)						(409)						(296)						—						—						(43,509)
Provision for income taxes			47						—						—						—						—						47
Net loss			$	(42,851)					$	(409)					$	(296)					$	—					$	—					$	(43,556)
Net loss per share attributable to common stockholders:(1)
Basic			$	(0.14)					$	—					$	—					$	—					$	—					$	(0.15)
Diluted			$	(0.14)					$	—					$	—					$	—					$	—					$	(0.15)
Other comprehensive loss:
Change in unrealized loss on available-for-sale investments, net of tax			—						—						—						—						—						—
Total other comprehensive loss			$	—					$	—					$	—					$	—					$	—					$	—
Total comprehensive loss			$	(42,851)					$	(409)					$	(296)					$	—					$	—					$	(43,556)

(1) Due to differences in rounding to the nearest cent per basic or diluted share, totals may not equal the sum of the line items.

			Three Months Ended June 30, 2020
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Revenue			$	58,878					$	(24)					$	(240)					$	—					$	—					$	58,614
Costs and expenses:
Cost of revenue			2,937						—						—						—						—						2,937
Research and development			4,518						—						—						—						—						4,518
Sales and marketing			52,369						416						—						—						—						52,785
General and administrative			11,642						—						44						—						—						11,686
Impairment of goodwill and long-lived assets			—						—						—						—						—						—
Total costs and expenses			71,466						416						44						—						—						71,926
Loss from operations			(12,588)						(440)						(284)						—						—						(13,312)
Interest expense, net			(957)						—						—						—						—						(957)
Change in fair value of common stock warrant liabilities			—						—						—						—						—						—
Other expense, net			(6,584)						—						—						—						—						(6,584)
Loss before income taxes			(20,129)						(440)						(284)						—						—						(20,853)
Provision for income taxes			28						—						—						—						—						28
Net loss			$	(20,157)					$	(440)					$	(284)					$	—					$	—					$	(20,881)
Net loss per share attributable to common stockholders:
Basic			$	(0.07)					$	—					$	—					$	—					$	—					$	(0.07)
Diluted			$	(0.07)					$	—					$	—					$	—					$	—					$	(0.07)
Other comprehensive loss:
Change in unrealized loss on available-for-sale investments, net of tax			—						—						—						—						—						—
Total other comprehensive loss			$	—					$	—					$	—					$	—					$	—					$	—
Total comprehensive loss			$	(20,157)					$	(440)					$	(284)					$	—					$	—					$	(20,881)

			Three Months Ended March 31, 2020
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Revenue			$	43,559					$	(17)					$	(170)					$	—					$	—					$	43,372
Costs and expenses:
Cost of revenue			2,767						—						—						—						—						2,767
Research and development			4,366						—						—						—						—						4,366
Sales and marketing			46,825						343						—						—						—						47,168
General and administrative			4,833						—						32						—						—						4,865
Impairment of goodwill and long-lived assets			—						—						—						—						—						—
Total costs and expenses			58,791						343						32						—						—						59,166
Loss from operations			(15,232)						(360)						(202)						—						—						(15,794)
Interest expense, net			(316)						—						—						—						—						(316)
Change in fair value of common stock warrant liabilities			—						—						—						—						—						—
Other income, net			51						—						—						—						—						51
Loss before income taxes			(15,497)						(360)						(202)						—						—						(16,059)
Provision for income taxes			25						—						—						—						—						25
Net loss			$	(15,522)					$	(360)					$	(202)					$	—					$	—					$	(16,084)
Net loss per share attributable to common stockholders:
Basic			$	(0.06)					$	—					$	—					$	—					$	—					$	(0.06)
Diluted			$	(0.06)					$	—					$	—					$	—					$	—					$	(0.06)
Other comprehensive loss:
Change in unrealized loss on available-for-sale investments, net of tax			—						—						—						—						—						—
Total other comprehensive loss			$	—					$	—					$	—					$	—					$	—					$	—
Total comprehensive loss			$	(15,522)					$	(360)					$	(202)					$	—					$	—					$	(16,084)

Condensed Consolidated Balance Sheets

The following unaudited condensed consolidated balance sheet tables present the impacts of the restatement adjustments as of the periods ended September 30, 2022 and 2021, June 30, 2022 and 2021, and March 31, 2022 and 2021. For the impacts of the restatement adjustments for the consolidated balance sheets as of December 31, 2021 refer to Note 3, Restatement of Previously Issued Financial Statements. The period ended December 31, 2022 was not subject to restatement and is presented in Part 1 of Item 8. Financial Statements.

			As of September 30, 2022
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Accounts receivable, net			$	9,001					$	—					$	—					$	—					$	(829)					$	8,172
Total current assets			492,446						—						—						—						(829)						491,617
Property and equipment, net			7,247						—						—						(2,466)						—						4,781
Operating lease right-of-use assets, net			13,366						—						—						(653)						—						12,713
Intangible assets, net			20,289						—						—						(264)						—						20,025
Goodwill			86,436						—						—						—						(973)						85,463
Total assets			772,414						—						—						(3,383)						(1,802)						767,229
Other current liabilities			45,890						9,972						10,254						—						(2,394)						63,722
Total current liabilities			53,222						9,972						10,254						—						(2,394)						71,054
Other long-term liabilities			1,687						—						—						—						(144)						1,543
Total liabilities			340,113						9,972						10,254						—						(2,538)						357,801
Additional paid-in capital			1,141,955						—						—						—						(199)						1,141,756
Accumulated deficit			(706,963)						(9,972)						(10,254)						(3,383)						935						(729,637)
Total stockholders’ equity			432,301						(9,972)						(10,254)						(3,383)						736						409,428
Total liabilities and stockholders’ equity			$	772,414					$	—					$	—					$	(3,383)					$	(1,802)					$	767,229

			As of June 30, 2022
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Accounts receivable, net			$	10,630					$	—					$	—					$	—					$	(391)					$	10,239
Total current assets			502,512						—						—						—						(391)						502,121
Goodwill			86,436						—						—						—						(973)						85,463
Total assets			858,903						—						—						—						(1,364)						857,539
Other current liabilities			54,838						9,985						9,246						—						(2,023)						72,046
Total current liabilities			58,379						9,985						9,246						—						(2,023)						75,587
Other long-term liabilities			1,180						—						—						—						(144)						1,036
Total liabilities			354,016						9,985						9,246						—						(2,167)						371,080
Additional paid-in capital			1,136,133						—						—						—						(435)						1,135,698
Accumulated deficit			(628,416)						(9,985)						(9,246)						—						1,238						(646,409)
Total stockholders’ equity			504,887						(9,985)						(9,246)						—						803						486,459
Total liabilities and stockholders’ equity			$	858,903					$	—					$	—					$	—					$	(1,364)					$	857,539

			As of March 31, 2022
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Accounts receivable, net			$	13,230					$	—					$	—					$	—					$	(303)					$	12,927
Total current assets			519,321						—						—						—						(303)						519,018
Goodwill			86,436						—						—						—						(973)						85,463
Total assets			932,536						—						—						—						(1,276)						931,260
Other current liabilities			57,607						8,849						7,591						—						(1,533)						72,514
Total current liabilities			72,917						8,849						7,591						—						(1,533)						87,824
Long-term debt, non-current			279,713						—						—						—						—						279,713
Other long-term liabilities			13,238						—						—						—						(144)						13,094
Total liabilities			380,898						8,849						7,591						—						(1,677)						395,661
Additional paid-in capital			1,121,697						—						—						—						(46)						1,121,651
Accumulated deficit			(567,805)						(8,849)						(7,591)						—						447						(583,798)
Total stockholders’ equity			551,638						(8,849)						(7,591)						—						401						535,599
Total liabilities and stockholders’ equity			$	932,536					$	—					$	—					$	—					$	(1,276)					$	931,260

Condensed Consolidated Balance Sheets, Fiscal year 2021

			As of September 30, 2021
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Accounts receivable, net			$	12,725					$	—					$	—					$	—					$	(2,039)					$	10,686
Total current assets			570,342						—						—						—						(2,039)						568,303
Goodwill			87,230						—						—						—						(973)						86,257
Total assets			811,132						—						—						—						(3,012)						808,120
Accounts payable			10,047						—						—						—						(1,137)						8,910
Other current liabilities			70,157						7,596						4,926						—						(1,310)						81,369
Total current liabilities			80,204						7,596						4,926						—						(2,447)						90,279
Total liabilities			106,796						7,596						4,926						—						(2,447)						116,871
Accumulated deficit			(320,721)						(7,596)						(4,926)						—						(565)						(333,808)
Total stockholders’ equity			704,336						(7,596)						(4,926)						—						(565)						691,249
Total liabilities and stockholders’ equity			$	811,132					$	—					$	—					$	—					$	(3,012)					$	808,120

			As of June 30, 2021
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Other current liabilities			$	35,531					$	6,926					$	3,743					$	—					$	—					$	46,200
Total current liabilities			124,934						6,926						3,743						—						—						135,603
Total liabilities			185,646						6,926						3,743						—						—						196,315
Accumulated deficit			(371,502)						(6,926)						(3,743)						—						—						(382,171)
Total stockholders’ equity			$	534,812					$	(6,926)					$	(3,743)					$	—					$	—					$	524,143

			As of March 31, 2021
			As Reported						End-User Liability						Indirect Taxes						Impairment						Other Adjustments						As Restated
Other current liabilities			$	29,860					$	6,413					$	2,682					$	—					$	—					$	38,955
Total current liabilities			40,098						6,413						2,682						—						—						49,193
Total liabilities			152,512						6,413						2,682						—						—						161,607
Accumulated deficit			(291,907)						(6,413)						(2,682)						—						—						(301,002)
Total stockholders’ equity			$	588,911					$	(6,413)					$	(2,682)					$	—					$	—					$	579,816

X

- References

No definition available.

+ Details

Name:	us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=126900988&loc=d3e1280-108306

+ Details

Name:	us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration